The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALBIREO PHARMA INC | COM | 01345P106 | 6,627 | 270,146 | SH | SOLE | 270,146 | 0 | 0 | ||
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 3,357 | 404,463 | SH | SOLE | 404,463 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 8,207 | 61,400 | SH | SOLE | 61,400 | 0 | 0 | ||
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 173 | 80,289 | SH | SOLE | 80,289 | 0 | 0 | ||
| ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 10,814 | 277,650 | SH | SOLE | 277,650 | 0 | 0 | ||
| ASGN INC | COM | 00191U102 | 4,780 | 87,700 | SH | SOLE | 87,700 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 6,242 | 275,941 | SH | SOLE | 275,941 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 4,272 | 209,088 | SH | SOLE | 209,088 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 8,770 | 103,000 | SH | SOLE | 103,000 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 3,684 | 466,900 | SH | SOLE | 466,900 | 0 | 0 | ||
| CENTENE CORP DEL | COM | 15135B101 | 2,883 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| CERECOR INC | COM | 15671L109 | 994 | 307,733 | SH | SOLE | 307,733 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 578 | 245,764 | SH | SOLE | 245,764 | 0 | 0 | ||
| CIGNA CORP NEW | COM | 125523100 | 13,921 | 73,300 | SH | SOLE | 73,300 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | COM | 189464100 | 1,079 | 60,100 | SH | SOLE | 60,100 | 0 | 0 | ||
| EVOLUS INC | COM | 30052C107 | 2,331 | 195,911 | SH | SOLE | 195,911 | 0 | 0 | ||
| GALAPAGOS NV | SPON ADR | 36315X101 | 5,766 | 62,850 | SH | SOLE | 62,850 | 0 | 0 | ||
| HANGER INC | COM NEW | 41043F208 | 22,539 | 1,189,399 | SH | SOLE | 1,189,399 | 0 | 0 | ||
| INTEC PHARMA LTD JERUSALEM | SHS | M53644106 | 5,098 | 676,104 | SH | SOLE | 676,104 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 9,403 | 1,062,500 | SH | SOLE | 1,062,500 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 4,445 | 316,581 | SH | SOLE | 316,581 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS INC | COM NEW | 53220K504 | 1,710 | 12,600 | SH | SOLE | 12,600 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 2,465 | 194,129 | SH | SOLE | 194,129 | 0 | 0 | ||
| MILLENDO THERAPEUTICS INC | COM | 60040X103 | 2,041 | 256,739 | SH | SOLE | 256,739 | 0 | 0 | ||
| OPTINOSE INC | COM | 68404V100 | 870 | 140,314 | SH | SOLE | 140,314 | 0 | 0 | ||
| PIERIS PHARMACEUTICALS INC | COM | 720795103 | 885 | 332,846 | SH | SOLE | 332,846 | 0 | 0 | ||
| PROVIDENCE SVC CORP | COM | 743815102 | 4,699 | 78,298 | SH | SOLE | 78,298 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 14,193 | 253,000 | SH | SOLE | 253,000 | 0 | 0 | ||
| SIERRA ONCOLOGY INC | COM | 82640U107 | 3,371 | 2,553,943 | SH | SOLE | 2,553,943 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 4,202 | 937,900 | SH | SOLE | 937,900 | 0 | 0 | ||
| TELIGENT INC NEW | COM | 87960W104 | 4,860 | 3,547,607 | SH | SOLE | 3,547,607 | 0 | 0 | ||
| TRIPLE-S MGMT CORP | CL B | 896749108 | 1,139 | 65,515 | SH | SOLE | 65,515 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 4,774 | 624,000 | SH | SOLE | 624,000 | 0 | 0 | ||
| WELLCARE HEALTH PLANS INC | COM | 94946T106 | 11,805 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| ZIMMER BIOMET HLDGS INC | COM | 98956P102 | 10,723 | 103,380 | SH | SOLE | 103,380 | 0 | 0 | ||